Working... Menu

Efficacy of Rechallenge With Sunitinib in Metastatic Pancreatic Neuroendocrine Tumor Previously Failed to Sunitinib (RESUNET)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02713763
Recruitment Status : Recruiting
First Posted : March 21, 2016
Last Update Posted : February 7, 2019
Apices Soluciones S.L.
Information provided by (Responsible Party):
Grupo Espanol de Tumores Neuroendocrinos

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : April 2019
  Estimated Study Completion Date : July 2019